Runliu Wu

2.4k total citations · 3 hit papers
31 papers, 1.7k citations indexed

About

Runliu Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Runliu Wu has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Runliu Wu's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (9 papers) and Ferroptosis and cancer prognosis (5 papers). Runliu Wu is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (9 papers) and Ferroptosis and cancer prognosis (5 papers). Runliu Wu collaborates with scholars based in China, United States and France. Runliu Wu's co-authors include Rui Kang, Daolin Tang, Nian Wang, Nian Wang, Changwei Lin, Lihua Huang, Guido Kroemer, Herbert J. Zeh, Xin Chen and Daojiang Li and has published in prestigious journals such as The Journal of Immunology, Oncogene and Gut.

In The Last Decade

Runliu Wu

30 papers receiving 1.7k citations

Hit Papers

The BET family in immunity and disease 2021 2026 2022 2024 2021 2021 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The BET family in immunity and disease
    2021 200 citations Nian Wang, Runliu Wu et al. Signal Transduction and Targeted Therapy profile →
  2. Tumor heterogeneity in autophagy-dependent ferroptosis
    2021 191 citations Runliu Wu, Xin Chen et al. Autophagy profile →
  3. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer
    2023 171 citations Jiao Liu, Zhuan Zhou et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runliu Wu China 19 1.2k 567 440 384 219 31 1.7k
Yuh‐Pyng Sher Taiwan 24 778 0.7× 373 0.7× 299 0.7× 382 1.0× 453 2.1× 52 1.7k
Satyaki Sengupta United States 10 1.5k 1.3× 231 0.4× 309 0.7× 479 1.2× 298 1.4× 15 1.8k
Markus A. Queisser United Kingdom 15 1.0k 0.9× 185 0.3× 330 0.8× 902 2.3× 262 1.2× 21 2.1k
Shaogui Wan China 23 709 0.6× 480 0.8× 147 0.3× 254 0.7× 263 1.2× 62 1.5k
Hassan Yousefi United States 19 1.8k 1.5× 1.1k 2.0× 174 0.4× 368 1.0× 299 1.4× 46 2.3k
Hua Geng China 19 897 0.8× 407 0.7× 169 0.4× 231 0.6× 206 0.9× 44 1.4k
Stephen G. Maher Ireland 20 853 0.7× 646 1.1× 252 0.6× 528 1.4× 514 2.3× 52 1.8k
Yan Jia China 25 1.0k 0.9× 354 0.6× 226 0.5× 162 0.4× 405 1.8× 89 1.8k
Temy Mo Yin Mok Hong Kong 2 1.0k 0.9× 147 0.3× 268 0.6× 447 1.2× 189 0.9× 2 1.3k
Gianfranco Mattia Italy 28 1.4k 1.2× 746 1.3× 250 0.6× 440 1.1× 361 1.6× 54 2.4k

Countries citing papers authored by Runliu Wu

Since Specialization
Citations

This map shows the geographic impact of Runliu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runliu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runliu Wu more than expected).

Fields of papers citing papers by Runliu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runliu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runliu Wu. The network helps show where Runliu Wu may publish in the future.

Co-authorship network of co-authors of Runliu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Runliu Wu. A scholar is included among the top collaborators of Runliu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runliu Wu. Runliu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Nian, Jiao Liu, Runliu Wu, et al.. (2025). A neuroimmune pathway drives bacterial infection. Science Advances. 11(18). eadr2226–eadr2226. 3 indexed citations
2.
Wang, Nian, Jiao Liu, Runliu Wu, et al.. (2025). A non-canonical immunometabolic function of BRD3 during sepsis. Developmental Cell. 61(2). 322–339.e6.
3.
Cai, Yiqing, Runliu Wu, Rui Kang, et al.. (2025). Itaconate drives pro-inflammatory responses through proteasomal degradation of GLO1. Biochemical and Biophysical Research Communications. 747. 151292–151292. 3 indexed citations
4.
Liu, Jiao, Zhuan Zhou, Runliu Wu, et al.. (2023). Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Science Translational Medicine. 15(720). eadg3049–eadg3049. 171 indexed citations breakdown →
5.
Wu, Runliu, Daolin Tang, & Rui Kang. (2023). Fluorogenic Probes for Intracellular Iron Detection. Methods in molecular biology. 2712. 1–8. 4 indexed citations
6.
Wu, Runliu, Jiao Liu, Nian Wang, et al.. (2022). Aconitate decarboxylase 1 is a mediator of polymicrobial sepsis. Science Translational Medicine. 14(659). eabo2028–eabo2028. 47 indexed citations
7.
Lu, Zhixing, Bowen Yu, Jiajia Zhao, et al.. (2022). COL5A1 Promotes the Progression of Gastric Cancer by Acting as a ceRNA of miR-137-3p to Upregulate FSTL1 Expression. Cancers. 14(13). 3244–3244. 13 indexed citations
8.
Long, Fei, Liang Li, Xiaorong Li, et al.. (2022). PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability. Cell Death and Disease. 13(2). 20 indexed citations
9.
Yang, Ying, Damián Gatica, Xu Liu, et al.. (2022). Upstream open reading frames mediate autophagy-related protein translation. Autophagy. 19(2). 457–473. 5 indexed citations
10.
Wu, Runliu, Rui Kang, & Daolin Tang. (2022). Mitochondrial ACOD1/IRG1 in infection and sterile inflammation. PubMed. 2(2). 78–88. 27 indexed citations
11.
Chen, Feng, Runliu Wu, Jiao Liu, et al.. (2022). The STING1-MYD88 complex drives ACOD1/IRG1 expression and function in lethal innate immunity. iScience. 25(7). 104561–104561. 34 indexed citations
12.
Wang, Nian, Runliu Wu, Daolin Tang, & Rui Kang. (2021). The BET family in immunity and disease. Signal Transduction and Targeted Therapy. 6(1). 23–23. 200 indexed citations breakdown →
13.
Wang, Nian, Runliu Wu, Paul B. Comish, Rui Kang, & Daolin Tang. (2021). Pharmacological Modulation of BET Family in Sepsis. Frontiers in Pharmacology. 12. 642294–642294. 10 indexed citations
14.
Wu, Runliu, Feng Chen, Nian Wang, Daolin Tang, & Rui Kang. (2020). ACOD1 in immunometabolism and disease. Cellular and Molecular Immunology. 17(8). 822–833. 122 indexed citations
15.
Wu, Yuanyuan, Gui Hu, Runliu Wu, & Ni Gong. (2020). High expression of miR-135b predicts malignant transformation and poor prognosis of gastric cancer. Life Sciences. 257. 118133–118133. 21 indexed citations
16.
Zhang, Hui, Ling Zeng, Min Xie, et al.. (2020). TMEM173 Drives Lethal Coagulation in Sepsis. Cell Host & Microbe. 27(4). 556–570.e6. 160 indexed citations
17.
Wu, Runliu, Liang Li, Yang Bai, et al.. (2020). The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression. Cell Death and Disease. 11(10). 908–908. 49 indexed citations
18.
Bai, Yang, Chunxing Yang, Runliu Wu, et al.. (2019). YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma. Frontiers in Oncology. 9. 332–332. 202 indexed citations
19.
20.
Du, Yuheng, Daojiang Li, Su Chen, et al.. (2018). POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling. Cell Death and Disease. 9(10). 995–995. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuh‐Pyng Sher Breakdown of academic impact, for papers by Satyaki Sengupta Breakdown of academic impact, for papers by Markus A. Queisser Breakdown of academic impact, for papers by Shaogui Wan Breakdown of academic impact, for papers by Hassan Yousefi Breakdown of academic impact, for papers by Hua Geng Breakdown of academic impact, for papers by Stephen G. Maher Breakdown of academic impact, for papers by Yan Jia Breakdown of academic impact, for papers by Temy Mo Yin Mok Breakdown of academic impact, for papers by Gianfranco Mattia
Rankless by CCL
2026